All In Biotech

Investigational drug · Phase 3

co-administration of cefepime

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia.

Phase 3

Last checked: Nov 20, 2026Latest source record: Apr 13, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

2

0 still active

All registered trials

2

Any phase or sponsor naming "co-administration of cefepime"

First trial start

2023

May 23, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "co-administration of cefepime", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Complicated Urinary Tract Infection
  • Acute Pyelonephritis
  • Hospital-acquired Bacterial Pneumonia
  • Ventilator-associated Bacterial Pneumonia
  • Complicated Intra-abdominal Infection
  • cUTI
  • AP

Approved drugs for the same conditions: Urinary tract infection · Pneumonia · Infectious disease and vaccines · Kidney and urology

Largest trials

Live from ClinicalTrials.gov: studies naming "co-administration of cefepime" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Complicated Urinary Tract Infection

  • Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • nacubactamPhase 32 trials

    Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • antibioticsPhase 23 trials

    TenNor Therapeutics (Zhongshan) Limited · Prosthetic Joint Infection (PJI), Periprosthetic Joint Infection (PJI), Acute Pyelonephritis

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.